Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.CancerRes I993;53:977—984. 18. Harary I, Farley B. In vitro studies on single beating rat heart cells. Exp Ceil Re
To investigate the feasibility of using human major histocompatibility complex class I chain-related...
Chemotherapeutic treatment of cancer patients is often unsuccessful, due to the involvement of vario...
99mTc-sestamibi (99mTc-MIBI) is a substrate for the P-glycoprotein (P-gp) pump but it is not known w...
Aim: Several cationic radiotracers originally developed as myocardial perfusion agents have shown po...
grantor: University of TorontoMultidrug resistance (MDR) describes a phenotype where resis...
Primary intrinsic and/or acquired multidrug resistance (MDR) is the main obstacle to successful canc...
Purpose: 99mTc-sestamibi(MIBI) and 99mTc-tetrofosmin have been used as substrates for P-glycoprotein...
[99mTc(N)(DBODC)(PNP5)]+ [DBODC is bis(N-ethoxyethyl)dithiocarbamato; PNP5 is bis(dimethoxypropylpho...
Abstract The multidrug-resistant phenotype is characterized by the reduced intracellular retention ...
Multidrug resistance remains the primary cause of treatment failure in cancer patients. Among the mu...
OBJECTIVE: Multidrug resistance (MDR) remains a major obstacle to suc-cessful chemotherapeutic treat...
Scintigraphic in vivo evaluation of complex cellular processes such as proliferation, apoptosis, rec...
Contains fulltext : 59201.pdf (publisher's version ) (Open Access)OBJECTIVES: It h...
Tc-99m-sestamibi (Tc-99m-MIBI) is a substrate for the P-glycoprotein (P-gp) pump but it is not known...
PURPOSE: P-glycoprotein (P-gp) is a membrane efflux pump protein that is involved in multidrug resis...
To investigate the feasibility of using human major histocompatibility complex class I chain-related...
Chemotherapeutic treatment of cancer patients is often unsuccessful, due to the involvement of vario...
99mTc-sestamibi (99mTc-MIBI) is a substrate for the P-glycoprotein (P-gp) pump but it is not known w...
Aim: Several cationic radiotracers originally developed as myocardial perfusion agents have shown po...
grantor: University of TorontoMultidrug resistance (MDR) describes a phenotype where resis...
Primary intrinsic and/or acquired multidrug resistance (MDR) is the main obstacle to successful canc...
Purpose: 99mTc-sestamibi(MIBI) and 99mTc-tetrofosmin have been used as substrates for P-glycoprotein...
[99mTc(N)(DBODC)(PNP5)]+ [DBODC is bis(N-ethoxyethyl)dithiocarbamato; PNP5 is bis(dimethoxypropylpho...
Abstract The multidrug-resistant phenotype is characterized by the reduced intracellular retention ...
Multidrug resistance remains the primary cause of treatment failure in cancer patients. Among the mu...
OBJECTIVE: Multidrug resistance (MDR) remains a major obstacle to suc-cessful chemotherapeutic treat...
Scintigraphic in vivo evaluation of complex cellular processes such as proliferation, apoptosis, rec...
Contains fulltext : 59201.pdf (publisher's version ) (Open Access)OBJECTIVES: It h...
Tc-99m-sestamibi (Tc-99m-MIBI) is a substrate for the P-glycoprotein (P-gp) pump but it is not known...
PURPOSE: P-glycoprotein (P-gp) is a membrane efflux pump protein that is involved in multidrug resis...
To investigate the feasibility of using human major histocompatibility complex class I chain-related...
Chemotherapeutic treatment of cancer patients is often unsuccessful, due to the involvement of vario...
99mTc-sestamibi (99mTc-MIBI) is a substrate for the P-glycoprotein (P-gp) pump but it is not known w...